智通财经APP讯,再鼎医药(09688)发布公告,于2025年5月12日(美国东部时间),本公司根据2024年股权激励计划向2名承授人涉及合共9800股美国存托股份的受限制股份单位。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.